Skip to main content

Periorbital Wrinkles

2
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Fitzpatrick Company
Fitzpatrick CompanyON - Waterloo
1 program
1
enhanced DefenAge 8-in-1 BioSerumPhase 3
MediCell Technologies
1 program
1
enhanced DefenAge 8-in-1 BioSerumPhase 31 trial
Active Trials
NCT05082766Unknown20Est. Dec 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MediCell Technologiesenhanced DefenAge 8-in-1 BioSerum

Clinical Trials (1)

Total enrollment: 20 patients across 1 trials

NCT05082766MediCell Technologiesenhanced DefenAge 8-in-1 BioSerum

Improvement in the Appearance of Periorbital Wrinkles

Start: Oct 2021Est. completion: Dec 202220 patients
Phase 3Unknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.